Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Celgene Corporation

NASDAQ: CELGZHealthcare / Biotechnology / USA
0.750000.00Vol 9 5001Y Perf -10.00%
Dec 13th, 2018 10:45
BID0.7000 ASK0.8500
Open0.7500 Previous Close0.7500
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★★     69.73
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Buy
Price Range Ratio 52wk %
25.20 
Earnings Date
-

Today's Price Range

0.72000.7700

 

52wk Range

0.11002.65

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-21.88%
3 Months
-51.61%
6 Months
120.59%
1 Year
-10.00%
3 Years
-25.00%
5 Years
-75.17%

Quotes

Name / TickerPriceChg.Chg.%
CELGZ0.75000.00000.00
AAPL171.192.09001.24
GOOG1 064.861.18000.11
MSFT109.100.02000.02
XOM76.810.79001.04
WFC47.49-0.2500-0.52
JNJ147.830.73000.50
FB143.96-0.5400-0.37
GE7.310.60008.94
JPM101.040.02000.02
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.80
Current Ratio
2.10
Long Term Debt to Total Capital
0.80
Total Debt to Equity
4.17
Interest Coverage
8.00
Leverage Ratio 6.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
96.40
EBIT Margin
37.60
EBITDA Margin
41.60
Pre-tax Profit Margin
26.40
Profit Margin
19.66
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
-
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-
Cash Flow Per Share
-
Price to Tangible Book
-
Book Value per Share
-
Enterprise Value (in ths.)
-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
32.29
ROE last 12 Months
39.32
Return on Assets (5Y Avg)
6.06
ROA last 12 Months
8.77
Return on Capital (5Y Avg)
14.26
ROC last 12 Months
13.36
Return on invested Capital Q
4.93
Return on invested Capital Y
14.95
Assets Turnover
0.20
Receivables Turnover
3.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
14 708 000
Revenue per Share
-
Revenue Growth 3 Years
16.19
Revenue Growth 5 Years
18.30
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume9 500
Shares Outstanding (in ths.)0
Trades Count8
Dollar Volume6 964
Avg. Volume32 195
Avg. Weekly Volume11 440
Avg. Monthly Volume15 790
Avg. Quarterly Volume17 894

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

44%56%

Bearish Bullish

63%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News